Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Pharma
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
At the Senate committee hearing on Novo Nordisk's Ozempic and Wegovy prices, insurance-related debate took up much of the conversation.
Zoey Becker
Sep 24, 2024 5:03pm
Lawmakers urge government to allow generics to Novo GLP-1s
Sep 23, 2024 5:28pm
Shortages of Novo Nordisk's Ozempic to persist into Q4
Sep 3, 2024 11:14am
Novo Nordisk rekindles heart failure hopes for semaglutide
Aug 30, 2024 11:48am
Novo Nordisk plans new $220M raw ingredients plant
Aug 16, 2024 11:20am
Novo Nordisk pulls Wegovy HF submission, will resubmit in 2025
Aug 7, 2024 10:30am
65e7.jpg?VersionId=HcEbagt.YOtkQVRw3roQO3uc2EWN6NJf)
